In this project we will focus on defining the process of elastolytic injury of pulmonary cells and their extracellular matrix. In particular, we aim to identify the function of heparan sulfate proteoglycans (HSPGs) as regulators of elastolysis and modulators of the cellular response to injury. In addition, we will investigate the consequences of elastase injury to the extracellular matrix on vascular endothelial growth factor (VEGF) storage, release, and activity. Our previous studies have implicated proteoglycans as central mediators of elastase damage to pulmonary cells and matrix. Specifically, we have shown that HSPGs modulate growth factor storage, release, and transport within the matrix;moreover, we have also found that elastase-generated HSPG fragments feed back to inhibit elastase and that elastase leads to increased nuclear HSPGs, reduced histone acetylation, reduced tropoelastin expression, and release of VEGF fragments. We plan to expand our studies to focus on the function of released fragments of HSPGs, the specific HSPGs, syndecans 1 and 4, and VEGF.
Our specific aims are to: 1) Identify the mechanisms and functional consequences of HSPG inhibition of elastase activity. 2) Define the mechanisms and functional consequences of elastase release of VEGF from pulmonary cells and matrix. 3) Determine the role of HSPGs in mediating the response of lung fibroblasts to elastase injury. We will use a combination of biochemical, molecular, and biophysical approaches in conjunction with cell culture and animal studies utilizing syndecan knock out mice to investigate the complex process of lung injury and repair. Ultimately, these studies will provide critical insight into the cascade of events initiated by elastolytic injury and the subsequent development of emphysema. Project Narrative: Chronic Obstructive Pulmonary Disease, which includes emphysema, is the fourth leading cause of death in the United States, accounting for more than 120,000 deaths in 2002. To develop effective therapies for this """"""""quiet killer"""""""" a more complete understanding of the underlying cellular and molecular causes is required. In the present project, we propose to identify new critical components of how the lung responds, appropriately and inappropriately, to a specific type of injury (elastolysis) so that this information might provide insight toward the development of therapies that aim to assist lung repair and avoid disease.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Lung Injury, Repair, and Remodeling Study Section (LIRR)
Program Officer
Croxton, Thomas
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Boston University
Schools of Medicine
United States
Zip Code
Sazonova, Olga V; Isenberg, Brett C; Herrmann, Jacob et al. (2015) Extracellular matrix presentation modulates vascular smooth muscle cell mechanotransduction. Matrix Biol 41:36-43
Hubbard, Brant; Buczek-Thomas, Jo Ann; Nugent, Matthew A et al. (2014) Heparin-dependent regulation of fibronectin matrix conformation. Matrix Biol 34:124-31
Nugent, M A; Zaia, J; Spencer, J L (2013) Heparan sulfate-protein binding specificity. Biochemistry (Mosc) 78:726-35
Imsirovic, Jasmin; Derricks, Kelsey; Buczek-Thomas, Jo Ann et al. (2013) A novel device to stretch multiple tissue samples with variable patterns: application for mRNA regulation in tissue-engineered constructs. Biomatter 3:
Derricks, Kelsey E; Rich, Celeste B; Buczek-Thomas, Jo Ann et al. (2013) Ascorbate enhances elastin synthesis in 3D tissue-engineered pulmonary fibroblasts constructs. Tissue Cell 45:253-60
Fannon, Michael; Forsten-Williams, Kimberly; Zhao, Bing et al. (2012) Facilitated diffusion of VEGF165 through descemet's membrane with sucrose octasulfate. J Cell Physiol 227:3693-700
Bais, Manish V; Nugent, Matthew A; Stephens, Danielle N et al. (2012) Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts. PLoS One 7:e31188
Naimy, Hicham; Buczek-Thomas, Jo Ann; Nugent, Matthew A et al. (2011) Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions. J Biol Chem 286:19311-9
Forsten-Williams, Kimberly; Kurtagic, Elma; Nugent, Matthew A (2011) Complex receptor-ligand dynamics control the response of the VEGF system to protease injury. BMC Syst Biol 5:170
Symes, Karen; Smith, Erin M; Mitsi, Maria et al. (2010) Sweet cues: How heparan sulfate modification of fibronectin enables growth factor guided migration of embryonic cells. Cell Adh Migr 4:507-10

Showing the most recent 10 out of 17 publications